Fungal Infections After Lung Transplantation

Area of Science:

• Medicine
• Transplantation Medicine
• Infectious Diseases

Background:

• Infection is a major cause of illness and death following lung transplant.
• Fungal infections, particularly invasive ones, are a serious concern in this patient population.
• Current strategies include antifungal prophylaxis or preemptive therapy for Aspergillus colonization.

Purpose of the Study:

• To summarize the challenges and risk factors associated with fungal infections post-lung transplant.
• To highlight the limitations of current antifungal strategies in preventing invasive fungal infections.

Main Methods:

• Review of existing literature on fungal infections after lung transplantation.
• Analysis of risk factors contributing to invasive fungal infections.
• Evaluation of the efficacy of antifungal prophylaxis and preemptive therapies.

Main Results:

• Invasive fungal infections continue to occur despite prophylactic or preemptive antifungal measures.
• Several risk factors are associated with increased susceptibility to fungal infections post-transplant.
• These include single lung transplant, pretransplant Aspergillus colonization, environmental exposures, underlying lung diseases (e.g., cystic fibrosis), increased immunosuppression, sinus disease, and airway stents.

Conclusions:

• Fungal infections remain a critical clinical challenge after lung transplantation.
• A comprehensive understanding of risk factors is essential for targeted prevention and management strategies.
• Further research may be needed to optimize antifungal approaches in lung transplant recipients.